Tatiana Obodzinskaya

Tatiana Obodzinskaya

Auto-generated profile, based on publicly available information

Tatiana Obodzinskaya

Clinic “PlanetaMed

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2021 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
IKI. V. Kukes
I. V. Kukes
JSJ. M. Salmasi
J. M. Salmasi
KTK. S. Ternovoy
K. S. Ternovoy
АKАlexander Kazimirskii
Аlexander Kazimirskii
TOT. E. Obodzinskaya
T. E. Obodzinskaya
AAA. D. Andreev
A. D. Andreev
SARS-CoV-2 is a novel coronavirus that has been identified as the cause of the 2019 coronavirus infection (COVID-19), which originated at Wuhan city of PRC in late 2019 and widespread worldwide. As the number of patients recovering from COVID-19 continue to grow, it’s very important to understand what health issues they may keep experiencing. COVID-19 is now recognized as an infectious disease that can cause multiple organ diseases of various localization. It is against this background that a new term was introduced: post-acute post-COVID-19 syndrome characterized by several persistent symptoms inherent in the acute phase of the disease, as well as the occurrence of delayed and (or) long-term complications beyond 4 weeks from the onset of the disease. The work reflected in this article revealed a portrait of a patient with post-COVID-19 syndrome, the most common complications of this period, as well as the mechanisms of their development and the resulting metabolic, cellular, tissue disorders leading to the tissue and organ dysfunctions. A comprehensive biochemical and immunological screening was carried out using the example of three clinical cases to identify the most significant disorders in these patients and to correlate with their clinical status over time. In point of fact, such patients were diagnosed with vascular dysfunction factors (development of endothelial dysfunction), metabolic dysfunction factors (metabolic acidosis, mitochondrial dysfunction, carbohydrate metabolism disorder, insulin resistance, altered branched-chain and aromatic amino acid metabolism), neurological disorder factors (neurotoxicity of the resulting metabolites), immunological disorder factors (decreased efficiency of detoxification systems, secondary immunodeficiency, risk of secondary bacterial infection).

23 October 2023 in Psychiatry (Moscow) (Psikhiatriya)
Verified
Journal Article
Open access
PDF file
VGV. O. Generalov
V. O. Generalov
TOT. E. Obodzinskaya
T. E. Obodzinskaya
TST. R. Sadykov
T. R. Sadykov
AYA. M. Yugay
A. M. Yugay
AAA. A. Aleksandrenkova
A. A. Aleksandrenkova
LNL. V. Niculina
L. V. Niculina
Background: neurodegenerative processes are prognostically dramatic conditions. They are actively studied by both neurologists and psychiatrists. Nosological forms are diverse and include regressive autism, dementia, multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, progressive epilepsy of infancy and childhood, generalized hyperkinesis, Tourette’s syndrome and many other conditions that are common to progressive neurological deficit, loss of cognitive functions, the appearance of nonspecific symptoms of brain irritation (epileptic seizures, hyperkinesis, dystonic states, stereotypes, psychotic episodes and other symptoms). Despite many ongoing studies the treatment of the described conditions is limited to temporary, incomplete and pharmacologically dependent relief of symptoms, since the problem of the etiopathogenesis of these conditions remains open. The aim of review is to present current immunological concepts of pathogenesis of neurodegenerative diseases. Material and method: using keywords “neuroinflammation, neurodegeneration, multiple sclerosis, Parkinson disease, epilepsy, parasitosis, microbiota” selected relevant scientific publications in domestic and international databases. Conclusion: recent advances in neuroimmunology show a significant role of neuroinflammation in the triggering and development of neurodegenerative processes, some of which are autoimmune in nature, which is confirmed by the indicators of immunity intensity introduced into clinical practice and by the detected antibody titers to brain tissues. In recent decades in a series of scientific works attention has been paid to the study of infectious agents detected in the immunological screening of patients with neurodegeneration, however, these data are fragmented and contradictory, and therefore are ignored by the medical community. This review presents a modern view of the etiopathogenesis of neurodegenerative diseases from the point of view of the summative antigenic burden, assessment of the immunological potential, homeostatic resource, and compensatory capabilities of the human body, which as a result can become a starting point for proposing new therapeutic strategies for the treatment of these intractable diseases.

29 August 2025 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
TKT.P. Klyushnik
T.P. Klyushnik
VGV.O. Generalov
V.O. Generalov
TOT.E. Obodzinskaya
T.E. Obodzinskaya
GLG.V. Larionov
G.V. Larionov
AAA.N. Aleksandrenkova
A.N. Aleksandrenkova
The presented literature review addresses factors and mechanisms of their influence on chronic inflammation throughout life, aggravating the severity of mental illness and contributing to its progression. Such factors include infections, intestinal microbiome disorders, lack of physical activity, overweight, chronic stress, and metabolic imbalance. Targeting these factors, in addition to standard drug therapy, can contribute to a mild course of the disease, improve the quality and duration of remissions, and, in some cases, overcome resistance to therapy.

24 October 2023 in Psychiatry (Moscow) (Psikhiatriya)
Verified
Journal Article
Open access
PDF file
TST. R. Sadykov
T. R. Sadykov
VGV. O. Generalov
V. O. Generalov
TOT. E. Obodzinskaya
T. E. Obodzinskaya
AYA. M. Yugay
A. M. Yugay
AAA. A. Aleksandrenkova
A. A. Aleksandrenkova
LNL. V. Niculina
L. V. Niculina
Background: despite the large number of newly emerging antiepileptic drugs, the frequency of treatment-resistant forms of epilepsy has not decreased, averaging 25–30%. Moreover the number of epileptic encephalopathies of early childhood has increased. One of the reasons of drug resistance is neuroinflammation. Aim: to evaluate the role of neuroinflammation in the pathogenesis of severe forms of childhood epilepsy and resistant adult epilepsy.Patients and methods: the main group 1 — 94 pediatric patients with epileptic encephalopathies, average age 20.4 ± 6.2 months. The control group 1 — 42 pediatric patients in remission of epilepsy, average age 21.3 ± 5.7 months. The main group 2 — 35 adult patients with resistant forms of epilepsy, average age 38.3 ± 7.9 years. The control group 2 — adult patients in remission of epilepsy 47 patients, average age 34.2 ± 8.6 years. The following blood levels were analyzed: neuron-specific enolase, S100 protein, eosinophilic cationic protein, IgE total level, total level of circulating immune complexes, leukocyte elastase and alpha-1 antitrypsin. Results: in the group of children with epileptic encephalopathies, an increase in neuroinflammation indicators was revealed in most patients. The average level of neuron-specific enolase is 27.6 ± 5.3 ng/ml compared to 14.2 ± 3.5 ng/ml in the control group. The average S100 protein level is 0.232 ± 0.041 ng/ml compared to 0.092 ± 0.024 ng/ml in the control group. The average level of eosinophilic cationic protein is 39.7 ± 9.4 ng/ml compared with 18.2 ± 5.3 ng/ml in the control group. The average IgE level is 157.3 ± 64.2 IU/ml compared to 42.2 ± 17.5 IU/ml in the control group. The average level of circulating immune complexes is 265.6 ± 54.4 UE/ml compared to 56.8 ± 16.8 UE/ml in the control group. In the group of adult patients with resistant forms of epilepsy, an increase in neuroinflammation indicators was revealed in most patients. The average level of neuron-specific enolase is 19.2 ± 7.2 ng/ml compared to 13.1 ± 4.1 ng/ml in the control group. The average S100 protein level is 0.115 ± 0.037 ng/ml compared to 0.093 ± 0.018 ng/ml in the control group. The average level of eosinophilic cationic protein is 24.2 ± 6.7 ng/ml compared to 18.8 ± 4.7 ng/ml in the control group. The average level of total IgE is 117.9 ± 32.6 IU/ml compared to 53.4 ± 18.2 IU/ml in the control group. The average level of circulating immune complexes is 235.2 ± 43.7 UE/ml compared to 62.6 ± 20.4 UE/ml in the control group. The level of leukocyte elastase was increased in 32 (91.4%) patients, the average level was 267.2 ± 36.8 nmol/min × ml compared with 175.2 ± 23.8 nmol/min × ml in the control group. The level of alpha-1 antitrypsin was increased in 33 (94.3%) patients, the average level was 55.2 ± 12.1 ng/ml compared with 26.4 ± 15.6 ng/ml in the control group. Conclusion: neuroinflammation is the factor of the development of severe forms of epilepsy and the formation of resistance in epileptic encephalopathies. Epileptic encephalopathies of early childhood according to their etiopathogenesis should be considered as subacute encephalitis, where seizures are only one sign of the pathological inflammatory process. The main clinical aim of the treatment of epileptic encephalopathies is the diagnosis of cumulative antigenic load and the selection of anti-inflammatory therapy.

24 September 2024 in City Healthcare
Verified
Journal Article
Open access
PDF file
ВГВасилий Олегович Генералов
Василий Олегович Генералов
TOTatiana Ye. Obodzinskaya
Tatiana Ye. Obodzinskaya
СПСергей Владимирович Приказчиков
Сергей Владимирович Приказчиков
АААнгелина Николаевна Александренкова
Ангелина Николаевна Александренкова
ТОТатьяна Евгеньевна Ободзинская
Татьяна Евгеньевна Ободзинская
Genetic pathologies remain a major challenge in modern medicine, although medical technologies, laboratory diagnostics, and targeted therapy tools have significantly developed and expanded. Since etiopathogenetic therapy is not provided, children with genetic disorders receive only symptomatic treatment stabilizing their status and mitigating life-threatening factors, but not contributing to even a partially functional recovery of damaged organs. Angelman syndrome is a rare and severe genetic pathology characterized by delayed psychomotor development, seizures, and conduct disorders. Patients with this diagnosis have, in general, a poor prognosis for development and socialization. Stem cell transplantation is a promising approach to treating various genetic, neurodegenerative, and autoimmune diseases. The article describes two clinical cases of patients with verified Angelman syndrome who received a combination therapy with stem cell transplantation as a key method. Health outcomes were analyzed using the data of physical examination, assessment of neurological and psychological statuses, testing methods of neuroimaging and functional medicine, and laboratory testing of hormonal, mitochondrial, immune states of patients. The results showed a significant improvement in patients’ psychomotor development and a positive dynamic in laboratory and functional indicators. Therefore, the studied combination therapy approach could become a promising method for treating patients with severe genetic diseases accompanied by serious nervous system damage.

7 August 2026 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
MOMaria Omel’chenko
Maria Omel’chenko
GLG.V. Larionov
G.V. Larionov
TKT.P. Klyushnik
T.P. Klyushnik
TOT.E. Obodzinskaya
T.E. Obodzinskaya
VGV.O. Generalov
V.O. Generalov
Objective. To establish a correlation between the severity of clinical symptoms in children diagnosed with autism spectrum disorders (ASDs) and the quality of life experienced by their parents, and identify potential targets for effective interventions in care. Material and methods. The study included a sample of 40 parents of children diagnosed with ASD and 37 parents of neurotypical children. The clinical and psychometric evaluation of the children with ASD was conducted using the Childhood Autism Rating Scale (CARS). Additionally, the Quality of Life in Autism Questionnaire (QoLA) was used to assess parents’ quality of life. Statistical analyses were performed using MS Excel and STATISTICA software, employing nonparametric methods. Results. The psychometric assessment using the CARS scale yielded an average score of 22.6±5.8 for the examined children, indicating a mild autism classification. The total QoLA score for parents of children with ASD was 132.6±25.8 points, compared with 171.8±23.6 points for parents of neurotypical children (p<0.001). The quality of life of parents, as assessed by Part B of the QoLA scale, was found to be correlated with the severity of ASD as measured by the CARS scale (p<0.05). The primary symptoms identified that negatively impacted the quality of life of parents included the social impairments associated with autism, challenges in collaborative engagement, a lack of comprehension regarding social rules and roles, alongside communication disorders (p<0.05). Conclusions. The findings highlight potential targets for social and therapeutic interventions with families, which may alleviate parental distress and enhance the quality of life for parents of children diagnosed with ASD.